In myeloid cell-specific SOCS3-conditional knockout mice, SOCS3−/− macrophages simultaneously suppressed inflammation and tumor metastasis [65]; therefore, SOCS3 is still considered a therapeutic target for cancer immunotherapy in DCs [66,67]. This evidence concerns the gene SOCS3 and cancer.